These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7770638)

  • 1. Fundamental concepts and immunosuppressive treatment in the various forms of glomerulonephritis.
    Keller F; Schwarz A
    Ren Fail; 1995 Jan; 17(1):1-11. PubMed ID: 7770638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T helper (Th)-cytokines in the urine of patients with primary glomerulonephritis treated with immunosuppressive drugs: Can they predict outcome?
    Kalavrizioti D; Gerolymos M; Rodi M; Kalliakmani P; Provatopoulou S; Eleftheriadis T; Mouzaki A; Goumenos DS
    Cytokine; 2015 Dec; 76(2):260-269. PubMed ID: 26307557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The advantages of immunosuppressive therapy in renal disease.
    Zucchelli P
    Ann Med Interne (Paris); 1988; 139(2):108-11. PubMed ID: 3293499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-neutrophil cytoplasmic antibodies (ANCA) in the glomerulonephritis].
    Kacprzyk F; Chrzanowski W
    Pol Arch Med Wewn; 1996 Jun; 95(6):514-23. PubMed ID: 9005420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum level and urinary excretion of RANTES in patients with primary glomerulonephritis].
    Kacprzyk F
    Pol Arch Med Wewn; 2002 Sep; 108(3):837-42. PubMed ID: 12600179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of asymptomatic and symptomatic childhood glomerulonephritis progressing to renal failure: a report of Kyushu Pediatric Nephrology Study Group.
    Hisano S; Tsuru N; Itoh Y; Hattori S; Yamashita F
    Pediatr Nephrol; 1994 Aug; 8(4):423-6. PubMed ID: 7947031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of cancer risk in glomerulonephritis.
    Heaf JG; Hansen A; Laier GH
    BMC Nephrol; 2018 Feb; 19(1):27. PubMed ID: 29394927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local macrophage proliferation in human glomerulonephritis.
    Yang N; Isbel NM; Nikolic-Paterson DJ; Li Y; Ye R; Atkins RC; Lan HY
    Kidney Int; 1998 Jul; 54(1):143-51. PubMed ID: 9648072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapidly progressive crescentic glomerulonephritis: Early treatment is a must.
    Moroni G; Ponticelli C
    Autoimmun Rev; 2014 Jul; 13(7):723-9. PubMed ID: 24657897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA fragmentation in chronic glomerulonephritis: an immunohistological analysis.
    Ott U; Aschoff A; Pocock J; Fünfstück R; Jirikowski G; Stein G; Wolf G
    Nephron Clin Pract; 2007; 105(1):c18-28. PubMed ID: 17114899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Instructions and implementations for percutaneous renal biopsy. Guidelines for the therapy of glomerular nephropaties].
    Cagnoli L;
    G Ital Nefrol; 2003; 20 Suppl 24():S3-47. PubMed ID: 14666502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of glomerulonephritis in children.
    Haycock GB
    Pediatr Nephrol; 1988 Apr; 2(2):247-55. PubMed ID: 3153019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrum and outcome of primary glomerulonephritis.
    Al Wakeel JS; Mitwalli AH; Tarif N; Alam AA; Hammad D; Abu-Aisha H; Memon N; Sulimani F; Askar A; Qudsi A
    Saudi J Kidney Dis Transpl; 2004; 15(4):440-6. PubMed ID: 17642779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology and prognosis of glomerulonephritis in Denmark 1985-1997.
    Heaf J; Løkkegaard H; Larsen S
    Nephrol Dial Transplant; 1999 Aug; 14(8):1889-97. PubMed ID: 10462267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reproducibility of the WHO classification of glomerulonephritis.
    Marcussen N; Olsen S; Larsen S; Starklint H; Thomsen OF
    Clin Nephrol; 1995 Oct; 44(4):220-4. PubMed ID: 8575120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prognosis in primary chronic glomerulonephritis in the adult. 298 clinicopathological cases (author's transl)].
    Legrain M; Salah H; Beaufils H; Flores Esteves L; Guedon J
    Nouv Presse Med; 1978 Feb; 7(7):533-8. PubMed ID: 643578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The current spectrum of infectious glomerulonephritis. Experience with 76 patients and review of the literature.
    Montseny JJ; Meyrier A; Kleinknecht D; Callard P
    Medicine (Baltimore); 1995 Mar; 74(2):63-73. PubMed ID: 7891544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myeloperoxidase Antineutrophil Cytoplasmic Antibody (MPO-ANCA) Associated Crescentic and Necrotizing Glomerulonephritis (GN) with Membranoproliferative GN Features.
    Koda R; Nagahori K; Kitazawa A; Imanishi Y; Yoshino A; Kawamoto S; Ueda Y; Takeda T
    Intern Med; 2016; 55(15):2043-8. PubMed ID: 27477412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum creatinine concentration and renal interstitial volume. Analysis of correlations in endocapillary (acute) glomerulonephritis and in moderately severe mesangioproliferative glomerulonephritis.
    Bohle A; Bader R; Grund KE; Mackensen S; Neunhoeffer
    Virchows Arch A Pathol Anat Histol; 1977 Aug; 375(2):87-96. PubMed ID: 143114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.